TY - JOUR AU - Rossios, C. AU - To, Y. AU - To, M. AU - Ito, M. AU - Kharitonov, S. A. AU - Barnes, P. J. PY - 2011 DA - 2011// TI - Long-acting fluticasone furoate has a superior pharmacological profile to fluticasone propionate in human respiratory cells JO - Eur J Pharmacol VL - 670 UR - https://doi.org/10.1016/j.ejphar.2011.08.022 DO - 10.1016/j.ejphar.2011.08.022 ID - Rossios2011 ER - TY - JOUR AU - Slack, R. J. AU - Barrett, V. J. AU - Morrison, V. S. AU - Sturton, R. G. AU - Emmons, A. J. AU - Ford, A. J. PY - 2013 DA - 2013// TI - In vitro pharmacological characterization of vilanterol, a novel long acting ß2–adrenoceptor agonist with 24 hour duration of action JO - J Pharmacol Exp Ther VL - 344 UR - https://doi.org/10.1124/jpet.112.198481 DO - 10.1124/jpet.112.198481 ID - Slack2013 ER - TY - JOUR AU - Bleecker, E. R. AU - Lötvall, J. AU - O’Byrne, P. M. AU - Woodcock, A. AU - Busse, W. W. AU - Kerwin, E. M. PY - 2014 DA - 2014// TI - Fluticasone furoate/vilanterol 100/25mcg compared with fluticasone furoate 100mcg in asthma: a randomized trial JO - J Allergy Clin Immunol Pract VL - 2 UR - https://doi.org/10.1016/j.jaip.2014.02.010 DO - 10.1016/j.jaip.2014.02.010 ID - Bleecker2014 ER - TY - JOUR AU - Busse, W. W. AU - O’Byrne, P. M. AU - Bleecker, E. R. AU - Lötvall, J. AU - Woodcock, A. AU - Andersen, L. PY - 2013 DA - 2013// TI - Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial JO - Thorax VL - 68 UR - https://doi.org/10.1136/thoraxjnl-2012-202606 DO - 10.1136/thoraxjnl-2012-202606 ID - Busse2013 ER - TY - JOUR AU - Bateman, E. D. AU - O’Byrne, P. M. AU - Busse, W. W. AU - Lötvall, J. AU - Bleecker, E. R. AU - Andersen, L. PY - 2014 DA - 2014// TI - Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone JO - Thorax VL - 69 UR - https://doi.org/10.1136/thoraxjnl-2013-203600 DO - 10.1136/thoraxjnl-2013-203600 ID - Bateman2014 ER - TY - JOUR AU - O’Byrne, P. M. AU - Bleecker, E. R. AU - Bateman, E. D. AU - Busse, W. W. AU - Woodcock, A. AU - Forth, R. PY - 2014 DA - 2014// TI - Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma JO - Eur Respir J VL - 43 UR - https://doi.org/10.1183/09031936.00064513 DO - 10.1183/09031936.00064513 ID - O’Byrne2014 ER - TY - JOUR AU - Woodcock, A. AU - Bleecker, E. R. AU - Lötvall, J. AU - O’Byrne, P. M. AU - Bateman, E. D. AU - Medley, H. PY - 2013 DA - 2013// TI - Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial JO - Chest VL - 144 UR - https://doi.org/10.1378/chest.13-0178 DO - 10.1378/chest.13-0178 ID - Woodcock2013 ER - TY - JOUR AU - Reddel, H. K. AU - Taylor, D. R. AU - Bateman, E. D. AU - Boulet, L. P. AU - Boushey, H. A. AU - Busse, W. W. PY - 2009 DA - 2009// TI - An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice JO - Am J Respir Crit Care Med VL - 180 UR - https://doi.org/10.1164/rccm.200801-060ST DO - 10.1164/rccm.200801-060ST ID - Reddel2009 ER - TY - JOUR AU - Shingo, S. AU - Zhang, J. AU - Reiss, T. F. PY - 2001 DA - 2001// TI - Correlation of airway obstruction and patient-reported endpoints in clinical studies JO - Eur Respir J VL - 17 UR - https://doi.org/10.1183/09031936.01.17202200 DO - 10.1183/09031936.01.17202200 ID - Shingo2001 ER - TY - JOUR AU - O’Byrne, P. M. AU - Barnes, P. J. AU - Rodriguez-Roisin, R. AU - Runnerstrom, E. AU - Sandstrom, T. AU - Svensson, K. PY - 2001 DA - 2001// TI - Low-dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial JO - Am J Respir Crit Care Med VL - 164 UR - https://doi.org/10.1164/ajrccm.164.8.2104102 DO - 10.1164/ajrccm.164.8.2104102 ID - O’Byrne2001 ER - TY - JOUR AU - Godard, P. AU - Greillier, P. AU - Pigearias, B. AU - Nachbaur, G. AU - Desfougeres, J. -. L. AU - Attali, V. PY - 2008 DA - 2008// TI - Maintaining asthma control in persistent asthma: Comparison of three strategies in a 6-month double-blind randomised study JO - Respir Med VL - 102 UR - https://doi.org/10.1016/j.rmed.2008.03.014 DO - 10.1016/j.rmed.2008.03.014 ID - Godard2008 ER - TY - JOUR AU - Chuchalin, A. AU - Jacques, L. AU - Frith, L. PY - 2008 DA - 2008// TI - Salmeterol/fluticasone propionate via Diskus™ once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids JO - Clin Drug Invest VL - 3 UR - https://doi.org/10.2165/00044011-200828030-00004 DO - 10.2165/00044011-200828030-00004 ID - Chuchalin2008 ER - TY - JOUR AU - Santanello, N. C. AU - Zhang, J. AU - Seidenberg, B. AU - Reiss, T. F. AU - Barber, B. L. PY - 1999 DA - 1999// TI - What are minimal important changes for asthma measures in a clinical trial? JO - Eur Respir J VL - 14 UR - https://doi.org/10.1034/j.1399-3003.1999.14a06.x DO - 10.1034/j.1399-3003.1999.14a06.x ID - Santanello1999 ER - TY - JOUR AU - Juniper, E. F. AU - Guyatt, G. H. AU - Willan, A. AU - Griffith, L. E. PY - 1994 DA - 1994// TI - Determining a minimal important change in a disease-specific quality of life questionnaire JO - J Clin Epidemiol VL - 47 UR - https://doi.org/10.1016/0895-4356(94)90036-1 DO - 10.1016/0895-4356(94)90036-1 ID - Juniper1994 ER - TY - JOUR AU - Smith, T. C. AU - Spiegelhalter, D. J. AU - Thomas, A. PY - 1995 DA - 1995// TI - Bayesian approaches to random-effects meta-analysis: a comparative study JO - Stat Med VL - 14 UR - https://doi.org/10.1002/sim.4780142408 DO - 10.1002/sim.4780142408 ID - Smith1995 ER - TY - JOUR AU - Sutton, A. J. AU - Abrams, K. R. PY - 2001 DA - 2001// TI - Bayesian methods in meta-analysis and evidence synthesis JO - Stat Methods Med Res VL - 10 UR - https://doi.org/10.1191/096228001678227794 DO - 10.1191/096228001678227794 ID - Sutton2001 ER - TY - JOUR AU - Sutton, A. J. AU - Higgins, J. P. PY - 2008 DA - 2008// TI - Recent developments in meta-analysis JO - Stat Med VL - 27 UR - https://doi.org/10.1002/sim.2934 DO - 10.1002/sim.2934 ID - Sutton2008 ER - TY - JOUR AU - Berry, S. M. AU - Shane Reese, C. AU - Larkey, P. D. PY - 1999 DA - 1999// TI - Bridging different eras in sports JO - J Amer Stat Assoc VL - 94 UR - https://doi.org/10.1080/01621459.1999.10474163 DO - 10.1080/01621459.1999.10474163 ID - Berry1999 ER - TY - BOOK AU - Gilks, W. R. AU - Richardson, S. PY - 1996 DA - 1996// TI - Spiegelhalter D PB - Hall CY - Markov Chain Monte Carlo In Practice ID - Gilks1996 ER - TY - JOUR AU - Valkenhoef, G. AU - Lu, G. AU - Brock, B. AU - Hillege, H. AU - Ades, A. E. AU - Welton, N. J. PY - 2012 DA - 2012// TI - Automating network meta-analysis JO - Res Synth Methods VL - 3 UR - https://doi.org/10.1002/jrsm.1054 DO - 10.1002/jrsm.1054 ID - Valkenhoef2012 ER - TY - JOUR AU - Lunn, D. J. AU - Thomas, A. AU - Best, N. AU - Spiegelhalter, D. PY - 2000 DA - 2000// TI - WinBUGS – a Bayesian modelling framework: concepts, structure and extensibility JO - Statistics and Computing VL - 10 UR - https://doi.org/10.1023/A:1008929526011 DO - 10.1023/A:1008929526011 ID - Lunn2000 ER - TY - BOOK AU - Gelman, A. AU - Carlin, J. B. AU - Stern, H. S. PY - 2003 DA - 2003// TI - Rubin DB PB - Bayesian Data Analysis CY - Hall/CRC ID - Gelman2003 ER - TY - JOUR AU - Bateman, E. D. AU - Silins, V. AU - Bogolubov, M. PY - 2001 DA - 2001// TI - Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 μg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma JO - Respir Med VL - 85 UR - https://doi.org/10.1053/rmed.2000.1008 DO - 10.1053/rmed.2000.1008 ID - Bateman2001 ER - TY - JOUR AU - Noord, J. A. AU - Lill, H. AU - Carrillo Diaz, T. AU - Greefhorst, A. P. AU - Davies, P. PY - 2001 DA - 2001// TI - Clinical equivalence of a salmeterol/fluticasone propionate combination product (50/500 μg) delivered via a chlorocarbon-free metered dose inhaler with the Diskus™ in patients with moderate to severe asthma JO - Clin Drug Invest VL - 21 UR - https://doi.org/10.2165/00044011-200121040-00002 DO - 10.2165/00044011-200121040-00002 ID - Noord2001 ER - TY - JOUR AU - Woodcock, A. AU - Bleecker, E. R. AU - Busse, W. W. AU - Lötvall, J. AU - Snowise, N. G. AU - Frith, L. PY - 2011 DA - 2011// TI - Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma JO - Respir Res VL - 12 UR - https://doi.org/10.1186/1465-9921-12-160 DO - 10.1186/1465-9921-12-160 ID - Woodcock2011 ER - TY - JOUR AU - Brown, P. J. AU - Greville, H. W. AU - Finucane, K. E. PY - 1984 DA - 1984// TI - Asthma and irreversible airflow obstruction JO - Thorax VL - 39 UR - https://doi.org/10.1136/thx.39.2.131 DO - 10.1136/thx.39.2.131 ID - Brown1984 ER - TY - JOUR AU - Caldwell, D. M. AU - Ades, A. E. AU - Higgins, J. P. PY - 2005 DA - 2005// TI - Simultaneous comparison of multiple treatments: combining direct and indirect evidence JO - BMJ VL - 331 UR - https://doi.org/10.1136/bmj.331.7521.897 DO - 10.1136/bmj.331.7521.897 ID - Caldwell2005 ER - TY - JOUR AU - Loymans, R. J. AU - Gemperli, A. AU - Cohen, J. AU - Rubinstein, S. M. AU - Sterk, P. J. AU - Reddel, H. K. PY - 2014 DA - 2014// TI - Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis JO - BMJ VL - 348 UR - https://doi.org/10.1136/bmj.g3009 DO - 10.1136/bmj.g3009 ID - Loymans2014 ER - TY - JOUR AU - Baker, W. L. AU - Baker, E. L. AU - Coleman, C. I. PY - 2009 DA - 2009// TI - Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis JO - Pharmacotherapy VL - 29 UR - https://doi.org/10.1592/phco.29.8.891 DO - 10.1592/phco.29.8.891 ID - Baker2009 ER - TY - JOUR AU - Mills, E. J. AU - Druyts, E. AU - Ghement, I. AU - Puhan, M. A. PY - 2011 DA - 2011// TI - Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis JO - Clin Epidemiol VL - 3 UR - https://doi.org/10.2147/CLEP.S16235 DO - 10.2147/CLEP.S16235 ID - Mills2011 ER -